22. Anti-depressants Flashcards

1
Q

What 2 types can psychoses be split into?

A
  • Schizophrenia (disorder of thought processes)

* Affective disorders (disorders of mood - mania + depression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common affective disorder?

A

Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the emotional symptoms of depression?

A
  • Misery
  • Apathy
  • Pessimism
  • Loss of motivation
  • Anhedonia (inability to feel pleasure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the biological symptoms of depression?

A
  • Slowing of thought and action
  • Loss of libido
  • Loss of appetite
  • Sleep disturbance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 2 main groups of depression?

A

Unipolar (depressive disorder) and bipolar (manic depression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe unipolar depression

A
  • Mood swings in the same direction
  • Late onset (adulthood)
  • Can be reactive (75%) or endogenous (25%)
  • Reactive: in response to stressful life events (non-familial)
  • Endogenous: unrelated to external stresses (familial pattern)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe bipolar depression

A
  • Oscillating depression and mania
  • Less common than unipolar depression
  • Early adult onset
  • Strong hereditary tendency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the drug treatment for bipolar depression?

A

Lithium - not conventional antidepressant, more mood-stabilising

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Summarise the monoamine theory of depression

A
  • Depression - functional deficit of central monoamine transmission
  • Mania - functional excess of central monoamine transmission
  • NA + 5-HT (serotonin) are the two monoamines involved
  • Based on pharmacological evidence - biochemical evidence in inconsistant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How quickly is an effect seen in the use of anti-depressant drugs?

A
  • Changes in the monoamines is rapid
  • However, the clinical effects can take weeks
  • Dissociation between the neurochemical change and antidepressant effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What receptors change in response to anti-depressants and how quickly does the change occur?

A

Down-regulation of α2, β and 5HT receptors
• Correlates with the onset of clinical drug effectiveness
• Therefore, this may be responsible for the clinical drug effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is the HPA (hypothalamic-pituitary-adrenal) axis involved in depression?

A
  • CRH (corticotropin-releasing hormone) levels increased in depressed patients
  • CRH stimulates the pituitary synthesis of ACTH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is seen in the hippocampus in chronic depression?

A

Hippocampal neurodegeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 2 main chemical groups of tri-cyclic antidepressants?

A

Dibenzazepines and dibenzocycloheptenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How do tri-cyclic antidepressants work?

A
  • Neuronal monoamine re-uptake inhibitors
  • Prevent reuptake of NA and 5-HT more than dopamine
  • Also act on α2 receptors, muscarinic AChRs, histamine receptors and 5-HT receptors - some of these actions are important but some contribute to the side-effects

(3 ringed structures)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What happens if TCAs bind to and antagonise alpha 2 receptors?

A
  • Block inhibitory control over NA

* Enhance release of NA into synaptic cleft

17
Q

What effect do TCAs have on β-adrenoceptors and 5-HT receptors?

A
  • Down-regulation

* Could cause the delayed onset of the anti-depressant

18
Q

Describe the absorption and protein binding of TCAs?

A
  • Rapid oral absorption

* Highly protein bound (90-95%)

19
Q

How are TCAs metabolised and what is the half life?

A
  • Hepatic metabolism - generates active metabolites
  • Renal excretion as glucuronide conjugates
  • Half-life: 10-20 hours
20
Q

What are the unwanted effects of TCAs at a therapeutic dosage?

A
  • Atropine-like effects - dry mouth, blurred vision, constipation, urinary retention (TCAs have muscarinic antagonist activities)
  • Postural hypotension - central effect
  • Sedation - due to H1 antagonism
21
Q

What are the unwanted effects of TCAs at acute toxicity?

A

CNS - excitement, delirium, seizures, coma, respiratory depression

CVS - dysrhythmias, ventricular fibrillation, sudden death

22
Q

Outline the drug interactions of TCAs

A

Plasma protein binding
• Increased TCA effects when co-administered with aspirin and phenytoin
• Warfarin can displace TCAs from their binding sites - toxic levels of TCA

Hepatic microsomal enzymes
• These metabolise TCAs
• If drugs are metabolised by the same enzyme (e.g. oral contraceptives), TCA effect increases

  • Potentiation of CNS depressants (alcohol) with TCAs
  • Interaction with antihypertensives
23
Q

Describe the action of monoamine oxidase inhibitors

A
  • Most are non-selective - can inhibit MAO-A and MAO-B
  • May result in the inhibition of other enzymes
  • Inhibition is irreversible - long duration of action
  • Rapid increase in cytoplasmic NA and 5-HT
  • Down-regulation of β-adrenoreceptors and 5-HT receptors
24
Q

Which monoamines does MAO-A and MAO-B have a preference for?

A

MAO-A - NA and 5-HT

MAO-B - DA

25
Describe the chemical structure of MAO inhibitors
• Single rings structure • Phenelzine is a hydrazine - single ring with carbon side chain and a hydrazine functional group at the end - this group is very reactive - forms covalent bonds with the MAO enzyme
26
Describe the absorption, metabolism and half life of MAOIs
* Rapid oral absorption * Metabolised in liver and excreted in urine * Short plasma half-life (but long action due to irreversible inhibition)
27
What are the unwanted effects of MAOIs
* Atropine-like effects * Postural hypotension * Sedation with long-term usage * Weight gain * Hepatotoxicity
28
Describe the drug/chemical interactions of MAOIs
Tyramine • Indirectly acting sympathomimetic amine • Metabolised by MAOs • Tyramine-containing foods (e.g. cheese) + MAOI => hypertensive crisis • Throbbing headache, increased BP, intracranial haemorrhage Pethidine (opioid) - hyperperexia, restlessness, coma, HT
29
Which MAOI has fewer drug interactions?
* Moclobemide * Reversible MAO-A inhibitor * Selective * However, shorter duration of action
30
How do selective serotonin reuptake inhibitors (SSRIs), e.g. fluoxetine, work?
* Selective 5-HT re-uptake inhibition | * Increased plasma 5-HT
31
How safe and effective are SSRIs?
* Safe in case of overdose - less troublesome side-effects | * Less effective against severe depression - still need other classes of drugs
32
What is the half-life of SSRIs and how often is it administered?
* Half-life - 18-24 hours | * Given once a day, orally
33
Describe the onset of action of SSRIs
* Delayed | * 2-4 weeks before optimal anti-depressant action
34
Why should co-administration of SSRIs with TCAs be avoided?
Competition for hepatic enzymes
35
Briefly describe the chemical structure of SSRIs
Couple of ring structures with an aliphatic side chain
36
What are the unwanted effects of SSRIs?
* GI side effects e.g. nausea, diarrhoea * Insomnia * Loss of libido
37
What is the most prescribe antidepressant drug?
Fluoxetine (Prozac) - SSRI
38
How do SNRIs (e.g. venlafaxine) work and when are they used?
* Dose-dependent re-uptake inhibition of 5-HT and NA * 5-HT > NA - so if you have a high dose, you can inhibit the dopamine transporter too * 2nd line treatment
39
How do α2 receptor antagonist work and what patients are they used for?
* Increases NA and 5-HT release in the brain * Other receptor interactions may contribute to antidepressant activity * Useful in SSRI-intolerant patients